Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Comment by Metalsguy1on Jul 13, 2022 3:06pm
263 Views
Post# 34821730

RE:Echelon Confirms $3.75 Target

RE:Echelon Confirms $3.75 Target
Steadfast. Over decades I have never ever seen a penny stock move with any conviction based on a price target. We had a price target of 1 for years. It's Luke saying it will rain during a drought. Eventually it does but it may take years but the prediction is irrelevant. Downward pressure us unabated.. 1. Finding Waldo is more fun and easier to do than patientb7. 2. Scaling the pouch is apparently a challenge. 3. Low valuation of viacyte bodes ill. 4. SvA would be profitable if changed its business to a travel agency sending management to conferences and assigned Selfie to selling used cars. For all the fools who have said just move on...what you see now are shareholders probably selling to exercise warrants. Imagine Where we would be if they were moving on. For years they have been chasing institutional investors with zero success. We are bagholders in a big con game.
<< Previous
Bullboard Posts
Next >>